Lisa Pleyer

Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group

Lisa Pleyer, Sonja Burgstaller, Michael Girschikofsky et al. · Annals of Hematology · 2014 · 93 citations · Full text

Hematological Malignancy, Austrian Azacitidine Registry, Agmt-study Group +13

TIGIT expressing CD4+T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemia

Kemal Catakovic, Franz Josef Gassner, Christoph Ratswohl et al. · OncoImmunology · 2017 · 77 citations · Full text

Azacitidine in CMML: Matched-pair analyses of daily-life patients reveal modest effects on clinical course and survival

Lisa Pleyer, Ulrich Germing, Wolfgang R. Sperr et al. · Leukemia Research · 2014 · 66 citations

Azacitidine in patients with WHO-defined AML – Results of 155 patients from the Austrian Azacitidine Registry of the AGMT-Study Group

Lisa Pleyer, Reinhard Stauder, Sonja Burgstaller et al. · Journal of Hematology & Oncology · 2013 · 60 citations · Full text

Azacitidine frontline therapy for unfit acute myeloid leukemia patients: Clinical use and outcome prediction

Fernando Ramos, Sylvain Thépot, Lisa Pleyer et al. · Leukemia Research · 2015 · 54 citations · Full text

Hematological Malignancy, Medicine, Mixed-phenotype Acute Leukemia +11